Alps Advisors Inc Aurinia Pharmaceuticals Inc. Transaction History

Alps Advisors Inc

$17.8 Billion
Q3 2025

A detailed history of Alps Advisors Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 61,065 shares of AUPH stock, worth $937,347. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,065

Previous 72,863 16.19%

Holding current value

$937,347

Previous $617,000 9.24%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$7.47 - $13.14 $88,131 - $155,025	-11,798 Reduced 16.19%	61,065 $674,000
Q2 2025 Aug 11, 2025	SELL	$7.2 - $8.64 $186,904 - $224,285	-25,959 Reduced 26.27%	72,863 $617,000
Q1 2025 Apr 30, 2025	SELL	$7.55 - $8.77 $127,972 - $148,651	-16,950 Reduced 14.64%	98,822 $794,000
Q4 2024 Feb 13, 2025	BUY	$6.75 - $10.44 $47,513 - $73,487	7,039 Added 6.47%	115,772 $1.04 Million
Q3 2024 Nov 12, 2024	SELL	$5.32 - $7.33 $15,039 - $20,721	-2,827 Reduced 2.53%	108,733 $797,000

Q2 2024 Aug 13, 2024	BUY	$4.81 - $5.78 $45,954 - $55,222	9,554 Added 9.37%	111,560 $637,000
Q1 2024 May 14, 2024	BUY	$4.93 - $9.31 $7,306 - $13,797	1,482 Added 1.47%	102,006 $511,000
Q4 2023 Feb 14, 2024	SELL	$7.13 - $9.49 $37,696 - $50,173	-5,287 Reduced 5.0%	100,524 $903,000
Q3 2023 Nov 14, 2023	BUY	$7.77 - $12.27 $5,229 - $8,257	673 Added 0.64%	105,811 $822,000
Q2 2023 Aug 14, 2023	BUY	$8.96 - $11.69 $100,405 - $130,998	11,206 Added 11.93%	105,138 $1.02 Million
Q1 2023 May 10, 2023	SELL	$5.94 - $11.27 $15,176 - $28,794	-2,555 Reduced 2.65%	93,932 $1.03 Million
Q4 2022 Feb 14, 2023	BUY	$4.11 - $8.14 $78,057 - $154,594	18,992 Added 24.51%	96,487 $416,000
Q3 2022 Nov 14, 2022	SELL	$6.66 - $12.39 $43,889 - $81,650	-6,590 Reduced 7.84%	77,495 $583,000
Q2 2022 Aug 11, 2022	BUY	$8.95 - $12.8 $752,560 - $1.08 Million	84,085 New	84,085 $845,000
Q4 2021 Feb 09, 2022	SELL	$17.78 - $33.08 $2.79 Million - $5.2 Million	-157,076 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$10.93 - $23.55 $115,038 - $247,863	-10,525 Reduced 6.28%	157,076 $3.48 Million
Q2 2021 Aug 11, 2021	SELL	$10.0 - $14.52 $611,760 - $888,275	-61,176 Reduced 26.74%	167,601 $2.17 Million
Q1 2021 May 07, 2021	BUY	$12.3 - $18.73 $11,832 - $18,018	962 Added 0.42%	228,777 $2.97 Million
Q4 2020 Feb 03, 2021	BUY	$12.94 - $16.05 $859,940 - $1.07 Million	66,456 Added 41.19%	227,815 $3.15 Million
Q3 2020 Nov 04, 2020	BUY	$13.19 - $16.66 $103,079 - $130,197	7,815 Added 5.09%	161,359 $2.38 Million
Q2 2020 Aug 05, 2020	BUY	$14.12 - $18.33 $2.17 Million - $2.81 Million	153,544 New	153,544 $2.5 Million
Q4 2017 Feb 05, 2018	SELL	$4.53 - $7.09 $372,198 - $582,535	-82,163 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$5.71 - $6.9 $469,150 - $566,924	82,163	82,163 $515,000

Others Institutions Holding AUPH

# of Institutions

268

Shares Held

69.3M

Call Options Held

984K

Put Options Held

574K

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $2.18B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Aurinia Pharmaceuticals Inc. Transaction History